Gestational Diabetes Among the Arsenic-Exposed Women from Arsenic-Contaminated Area of Bangladesh

Introduction

Arsenic contamination of groundwater represents one of the most devastating environmental health crises of the modern era. Bangladesh is the most severely affected country, where naturally occurring arsenic in geological formations leaches into shallow tube wells that serve as the primary drinking water source for millions of rural inhabitants. The World Health Organization has described the situation as the largest mass poisoning of a population in history, with an estimated tens of millions of Bangladeshis exposed to arsenic concentrations exceeding the WHO guideline value of 10 micrograms per litre.

Chronic arsenic exposure through drinking water has been associated with a broad spectrum of adverse health effects, including arsenicosis (the clinical manifestation of chronic arsenic poisoning characterised by skin lesions), cardiovascular disease, neurological disorders, respiratory diseases, and various cancers of the skin, bladder, lung, kidney, and liver. Increasingly, evidence has also linked arsenic exposure with metabolic disruption, including impaired glucose tolerance and elevated risk of type 2 diabetes mellitus in adults.

Gestational diabetes mellitus (GDM) — defined as glucose intolerance first recognised during pregnancy — is a common obstetric complication with significant consequences for both mothers and their offspring. GDM is associated with increased risk of pre-eclampsia, caesarean delivery, macrosomia, neonatal hypoglycaemia, and long-term metabolic risk for both mother and child. This study investigated the relationship between arsenic exposure and gestational diabetes among women living in arsenic-contaminated areas of Bangladesh.

Study Design and Methods

The researchers conducted a study among pregnant women residing in areas of Bangladesh known to have arsenic-contaminated groundwater. Arsenic exposure was assessed through measurement of arsenic concentrations in the participants’ primary drinking water sources. Gestational diabetes was diagnosed according to established clinical criteria. The study compared GDM prevalence between women with higher arsenic exposure and those with lower exposure levels, controlling for established confounders including age, body mass index, family history of diabetes, parity, and socio-economic factors.

Arsenic Exposure and Gestational Diabetes

The study’s findings demonstrated an association between arsenic exposure from contaminated drinking water and the occurrence of gestational diabetes mellitus. Women exposed to higher concentrations of arsenic in their drinking water showed elevated rates of GDM compared to those with lower exposure. This finding is consistent with a growing body of international evidence linking arsenic exposure during pregnancy with impaired glucose metabolism.

Meta-analyses synthesising the available evidence have reported an overall pooled risk of approximately 1.56 (95% CI: 1.23–1.99) for the association between arsenic exposure and GDM, with moderate heterogeneity across studies. Research from diverse geographic settings — including the United States, Chile, China, and Bangladesh — has contributed to this evidence base, with somewhat higher risks observed in Asian populations and in studies using urinary arsenic biomarkers as the exposure metric.

Biological Mechanisms

Several biologically plausible mechanisms have been proposed to explain the relationship between arsenic exposure and glucose intolerance. Arsenic is known to interfere with insulin signalling pathways, potentially through inhibition of insulin-stimulated glucose uptake in peripheral tissues. Experimental studies have demonstrated that arsenic can impair pancreatic beta cell function, reducing insulin secretion capacity. Arsenic-induced oxidative stress and inflammatory responses may further contribute to metabolic disruption.

During pregnancy, these mechanisms may interact with the normal physiological insulin resistance that develops to support foetal growth, tipping the balance toward overt hyperglycaemia in susceptible women. The developing foetus may also be directly affected, as arsenic crosses the placental barrier and can influence foetal metabolic programming, potentially increasing the offspring’s long-term risk of metabolic disease.

The Bangladesh Arsenic Crisis: Context

Bangladesh’s arsenic contamination crisis has its roots in a well-intentioned but ultimately devastating public health intervention. In the 1970s and 1980s, international agencies promoted the drilling of shallow tube wells as an alternative to contaminated surface water sources that were causing widespread diarrheal disease and child mortality. The tube wells successfully reduced waterborne infections, but the arsenic naturally present in the underlying sedimentary geology was not tested for, and millions of wells were installed without screening for arsenic content.

Despite decades of awareness and mitigation efforts, millions of Bangladeshis continue to be exposed to elevated arsenic levels through their drinking water and, increasingly, through the food chain, as arsenic is taken up by rice and vegetables irrigated with contaminated groundwater. The health consequences continue to manifest across multiple organ systems and generations.

Implications for Maternal Health

The findings of this study reinforce the importance of arsenic mitigation as a maternal health intervention, not solely an environmental remediation concern. Ensuring that pregnant women have access to arsenic-safe drinking water should be recognised as a priority within maternal healthcare programmes in arsenic-affected regions. This may involve provision of deep tube wells accessing arsenic-free aquifers, household water treatment systems, rainwater harvesting, or piped water supply where feasible.

From a clinical perspective, the study supports heightened vigilance for gestational diabetes among pregnant women with known arsenic exposure. Enhanced screening protocols and closer glycaemic monitoring may be warranted in arsenic-affected populations, enabling earlier detection and management of GDM to reduce adverse outcomes for both mother and child.

Limitations

The study’s exposure assessment relied on drinking water arsenic concentrations, which may not fully capture total arsenic exposure through food and other sources. The cross-sectional design limits causal inference. Residual confounding by unmeasured factors associated with both arsenic exposure and GDM risk (such as nutritional status and dietary patterns) cannot be entirely excluded. The generalisability of findings may be limited to populations with similar exposure profiles and genetic backgrounds.

Significance

This study contributes valuable evidence from a highly affected population to the growing understanding of arsenic’s metabolic effects during pregnancy. As the international community continues to address the legacy of arsenic contamination in Bangladesh and other affected regions, understanding the full spectrum of health consequences — including reproductive and metabolic outcomes — is essential for designing comprehensive public health responses.

← Back to MJPHM Homepage